In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 28th, 2005 | 21 | No |
Popular Name: ANDROSTENEDIONE ANDROSTENEDIONE
Find On: PubMed — Wikipedia — Google
CAS Numbers: 137071-32-0 , 25975-59-1 , 571-36-8 , 63-05-8 , [63-05-8]
4-Androstene-3,17-dione; 63-05-8; Androst-4-ene-3,17-dione; Androstenedione; C00280
4-androstene-3,17-dione; 63-05-8; ANDROST4ENE; androst-4-ene-3,17-dione; androstenedione
4-Androstenedione;4-Androstene-3,17-dione
5-Androstene-3,17-dione; 571-36-8; C20252
63-05-8; Androstenedione (JAN); D00051
CHEBI:40930; CHEBI:11964; CHEBI:20322; CHEBI:13830; CHEBI:2709
Delta(4)-androsten-3,17-dione; Delta(4)-androstene-3,17-dione; androstenedione
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.06 | 9.29 | -10.68 | 0 | 2 | 0 | 34 | 286.415 | 0 | ↓ |
Ref Reference (pH 7) | 3.06 | 9.39 | -9.03 | 0 | 2 | 0 | 34 | 286.415 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
MP | 171 | TCI |
ALOGPS_SOLUBILITY | 2.70e-02 g/l | DrugBank-experimental |
UniProt Database Links | 3BHD_COMTE; 3BHS1_HUMAN; 3O1D_MYCS2; 5BPOR_DIGLA; AK1C3_HUMAN; AK1C3_PONAB; AK1CL_MOUSE; AK1D1_HUMAN; AK1D1_MOUSE; AK1D1_RABIT; AK1D1_RAT; CP17A_BISBI; CP17A_BOVIN; CP17A_CAPHI; CP17A_CAVPO; CP17A_CHICK; CP17A_FELCA; CP17A_HORSE; CP17A_HUMAN; CP17A_ICTPU | ChEBI |
Purity | 97% | APIChem |
Patent Database Links | EP1623712; US2005143366; US2007184429; US2008014642 | ChEBI |
Reactome Database Links | REACT_10013; REACT_10056; REACT_9948; REACT_9954 | ChEBI |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CP19A-2-E | Cytochrome P450 19A1 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 300 | 0.43 | Binding ≤ 10μM |
DHB3-3-E | Estradiol 17-beta-dehydrogenase 3 (cluster #3 Of 4), Eukaryotic | Eukaryotes | 758 | 0.41 | Binding ≤ 10μM |
S5A1-1-E | Steroid 5-alpha-reductase 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2700 | 0.37 | Binding ≤ 10μM |
S5A2-1-E | Steroid 5-alpha-reductase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 84 | 0.47 | Binding ≤ 10μM |
ANDR-2-E | Androgen Receptor (cluster #2 Of 3), Eukaryotic | Eukaryotes | 64 | 0.48 | Functional ≤ 10μM |
Z50425-4-O | Plasmodium Falciparum (cluster #4 Of 22), Other | Other | 10000 | 0.33 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CP19A_HUMAN | P11511 | Cytochrome P450 19A1, Human | 20 | 0.51 | Binding ≤ 1μM |
DHB3_HUMAN | P37058 | Estradiol 17-beta-dehydrogenase 3, Human | 489 | 0.42 | Binding ≤ 1μM |
S5A2_HUMAN | P31213 | Steroid 5-alpha-reductase 2, Human | 83.9 | 0.47 | Binding ≤ 1μM |
CP19A_HUMAN | P11511 | Cytochrome P450 19A1, Human | 20 | 0.51 | Binding ≤ 10μM |
DHB3_HUMAN | P37058 | Estradiol 17-beta-dehydrogenase 3, Human | 489 | 0.42 | Binding ≤ 10μM |
S5A1_HUMAN | P18405 | Steroid 5-alpha-reductase 1, Human | 2700 | 0.37 | Binding ≤ 10μM |
S5A2_HUMAN | P31213 | Steroid 5-alpha-reductase 2, Human | 83.9 | 0.47 | Binding ≤ 10μM |
ANDR_RAT | P15207 | Androgen Receptor, Rat | 64 | 0.48 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 10000 | 0.33 | Functional ≤ 10μM |
Description | Species |
---|---|
Androgen biosynthesis |
|
Endogenous sterols | |
Estrogen biosynthesis |
Description | Species |
---|---|
Androgen biosynthesis | |
Endogenous sterols | |
Estrogen biosynthesis | |
Nuclear Receptor transcription pathway | |
Synthesis of very long-chain fatty acyl-CoAs |